For condition: Hidradenitis Suppurativa
Clinical Trial for Hidradenitis Suppurativa (67 Weeks)
Study Summary
Who Can Participate?
People aged 16 and above diagnosed with hidradenitis suppurativa (HS) may participate.
Inclusion Criteria
- A clinical diagnosis of moderate to severe HS for at least 6 months
- Have the presence of HS lesions in at least 2 distinct anatomic areas
- Intolerance to oral antibiotics for HS treatment
What Are The Benefits?
- No cost to participate or receive treatment
- Regular visits with study doctors who specialize in treating HS (20 visits)
- Will receive either an investigative injection or a placebo
How Long Will The Study Last?
- Around 67 weeks
For more information about this trial, please visit ClinicalTrials.gov
